+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Parkinson's Disease - Pipeline Review, H2 2019

  • ID: 4894249
  • Drug Pipelines
  • December 2019
  • Region: Global
  • 1138 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 1st Bio Therapeutics Inc
  • Arvinas Inc
  • CHA Bio & Diostech Co Ltd
  • Genzyme Corp
  • Longevity Biotech Inc
  • NeuroPn Therapeutics LLC
  • MORE
Parkinson's Disease - Pipeline Review, H2 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease - Pipeline Review, H2 2019, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.

Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminergic neurons in substantia nigra. Symptoms generally develop slowly over years. People with PD experience dyskinesia, dystonia, tremor, stiffness and impaired locomotory functions. Risk factors include age, genetic factors, environmental factors and gender. Treatment options include anticholinergics, COMT inhibitors and dopamine agonists.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Parkinson's Disease - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Parkinson's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 10, 51, 55, 3, 202, 82 and 11 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Preclinical and Discovery stages comprises 1, 1, 50 and 15 molecules, respectively.

Parkinson's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Parkinson's Disease (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Parkinson's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Parkinson's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Parkinson's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Parkinson's Disease (Central Nervous System)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Parkinson's Disease (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Parkinson's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 1st Bio Therapeutics Inc
  • Arvinas Inc
  • CHA Bio & Diostech Co Ltd
  • Genzyme Corp
  • Longevity Biotech Inc
  • NeuroPn Therapeutics LLC
  • MORE
Introduction
Parkinson's Disease - Overview
Parkinson's Disease - Therapeutics Development
Parkinson's Disease - Therapeutics Assessment
Parkinson's Disease - Companies Involved in Therapeutics Development
Parkinson's Disease - Drug Profiles
Parkinson's Disease - Dormant Projects
Parkinson's Disease - Discontinued Products
Parkinson's Disease - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Parkinson's Disease, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Parkinson's Disease - Pipeline by 1st Bio Therapeutics Inc, H2 2019
Parkinson's Disease - Pipeline by 4D Pharma Plc, H2 2019
Parkinson's Disease - Pipeline by Abaxy Sprl, H2 2019
Parkinson's Disease - Pipeline by AbbVie Inc, H2 2019
Parkinson's Disease - Pipeline by Abivax SA, H2 2019
Parkinson's Disease - Pipeline by ABL Bio Inc, H2 2019
Parkinson's Disease - Pipeline by AC Immune SA, H2 2019
Parkinson's Disease - Pipeline by Acelot Inc, H2 2019
Parkinson's Disease - Pipeline by AcuraStem Inc, H2 2019
Parkinson's Disease - Pipeline by Addex Therapeutics Ltd, H2 2019
Parkinson's Disease - Pipeline by Advanced Medical Projects, H2 2019
Parkinson's Disease - Pipeline by Afecta Pharmaceuticals Inc, H2 2019
Parkinson's Disease - Pipeline by Affichem SA, H2 2019
Parkinson's Disease - Pipeline by AFFiRiS AG, H2 2019
Parkinson's Disease - Pipeline by Alan Laboratories Inc, H2 2019
Parkinson's Disease - Pipeline by Alectos Therapeutics, H2 2019
Parkinson's Disease - Pipeline by Alexza Pharmaceuticals Inc, H2 2019
Parkinson's Disease - Pipeline by Alion Pharmaceuticals Inc, H2 2019
Parkinson's Disease - Pipeline by Alkahest Inc, H2 2019
Parkinson's Disease - Pipeline by Alkermes Plc, H2 2019
Parkinson's Disease - Pipeline by Allife Medical Science and Technology Co Ltd, H2 2019
Parkinson's Disease - Pipeline by Alterity Therapeutics Ltd, H2 2019
Parkinson's Disease - Pipeline by Amabiotics SAS, H2 2019
Parkinson's Disease - Pipeline by Amarantus Bioscience Holdings Inc, H2 2019
Parkinson's Disease - Pipeline by Amathus Therapeutics Inc, H2 2019
Parkinson's Disease - Pipeline by Amneal Pharmaceuticals Inc, H2 2019
Parkinson's Disease - Pipeline by Anavex Life Sciences Corp, H2 2019
Parkinson's Disease - Pipeline by Anida Pharma Inc, H2 2019
Parkinson's Disease - Pipeline by Annovis Bio Inc, H2 2019
Parkinson's Disease - Pipeline by Antoxis Ltd, H2 2019
Parkinson's Disease - Pipeline by Aoxing Pharmaceutical Company Inc, H2 2019
Parkinson's Disease - Pipeline by APeT Holding BV, H2 2019
Parkinson's Disease - Pipeline by Apollo Therapeutics LLC, H2 2019
Parkinson's Disease - Pipeline by Appello Pharmaceuticals Inc, H2 2019
Parkinson's Disease - Pipeline by AptaBio Therapeutics Inc, H2 2019
Parkinson's Disease - Pipeline by Aptamer Sciences Inc, H2 2019
Parkinson's Disease - Pipeline by Araclon Biotech SL, H2 2019
Parkinson's Disease - Pipeline by Aranda Pharma Ltd, H2 2019
Parkinson's Disease - Pipeline by AriBio, H2 2019
Parkinson's Disease - Pipeline by ArmaGen Inc, H2 2019

List of Figures
Number of Products under Development for Parkinson's Disease, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • 1st Bio Therapeutics Inc
  • 4D Pharma Plc
  • Abaxy Sprl
  • AbbVie Inc
  • Abivax SA
  • ABL Bio Inc
  • AC Immune SA
  • Acelot Inc
  • AcuraStem Inc
  • Addex Therapeutics Ltd
  • Advanced Medical Projects
  • Afecta Pharmaceuticals Inc
  • Affichem SA
  • AFFiRiS AG
  • Alan Laboratories Inc
  • Alectos Therapeutics
  • Alexza Pharmaceuticals Inc
  • Alion Pharmaceuticals Inc
  • Alkahest Inc
  • Alkermes Plc
  • Allife Medical Science and Technology Co Ltd
  • Alterity Therapeutics Ltd
  • Amabiotics SAS
  • Amarantus Bioscience Holdings Inc
  • Amathus Therapeutics Inc
  • Amneal Pharmaceuticals Inc
  • Anavex Life Sciences Corp
  • Anida Pharma Inc
  • Annovis Bio Inc
  • Antoxis Ltd
  • Aoxing Pharmaceutical Company Inc
  • APeT Holding BV
  • Apollo Therapeutics LLC
  • Appello Pharmaceuticals Inc
  • AptaBio Therapeutics Inc
  • Aptamer Sciences Inc
  • Araclon Biotech SL
  • Aranda Pharma Ltd
  • AriBio
  • ArmaGen Inc
  • Arrien Pharmaceuticals LLC
  • Arvinas Inc
  • Asdera
  • Asklepios BioPharmaceutical Inc
  • AstraZeneca Plc
  • Athersys Inc
  • Athira Pharma Inc
  • AurimMed Pharma Inc
  • Auritec Pharmaceuticals Inc
  • Axial Biotherapeutics Inc
  • Axovant Gene Therapies Ltd
  • AZTherapies Inc
  • B&A Therapeutics
  • BCWorld Pharm Co Ltd
  • Belrose Pharma Inc
  • Berg LLC
  • Bial - Portela & Ca SA
  • Bio-Modeling Systems SAS
  • Bioasis Technologies Inc
  • BioElectron Technology Corp
  • Biogen Inc
  • BioHealthonomics Inc
  • BlueRock Therapeutics
  • BrainStorm Cell Therapeutics Inc
  • Bristol-Myers Squibb Co
  • C4X Discovery Holdings Plc
  • Calico LLC
  • Califia Bio Inc
  • Cantabio Pharmaceuticals Inc
  • Canvax Biotech SL
  • Capo Therapeutics Inc
  • Carmot Therapeutics Inc
  • Carna Biosciences Inc
  • Cavion LLC
  • CavoGene LifeSciences
  • CellCure
  • Cellivery Therapeutics Inc
  • Cellix Bio Pvt Ltd
  • Cerecin Inc
  • CereSpir Inc
  • Cerevance Inc
  • Cerevel Therapeutics LLC
  • CHA Bio & Diostech Co Ltd
  • Chase Therapeutics Corp
  • Chipscreen Biosciences Ltd
  • CholesteniX Ltd
  • Ci Therapeutics
  • Clayton Biotechnologies Inc
  • Clene Nanomedicine Inc
  • Clera Inc
  • Clevexel Pharma SAS
  • Cogentis Therapeutics Inc
  • Collaborative Medicinal Development LLC
  • Contera Pharma ApS
  • Copernicus Therapeutics Inc
  • Corium International Inc
  • Crossject SA
  • CuraSen Therapeutics Inc
  • Curemark LLC
  • CuroNZ Ltd
  • Curyx Bio Inc
  • Cypralis Ltd
  • DanPET AB
  • Declion Pharmaceuticals Inc
  • DegenRx BV
  • Denali Therapeutics Inc
  • DermaXon LLC
  • Diffusion Pharmaceuticals Inc
  • Dina Pharmaceuticals Inc
  • Dizlin Medical Design AB
  • Domain Therapeutics SA
  • DongKoo Bio & Pharma Co Ltd
  • E-scape Bio Inc
  • Easywell Biomedical Inc
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Emerald Health Sciences Inc
  • Energenesis Biomedical Co Ltd
  • Evgen Pharma Plc
  • Fabre-Kramer Pharmaceuticals Inc
  • Fortuna Fix Inc
  • Fulcrum Therapeutics Inc
  • GB Sciences Inc
  • Genervon Biopharmaceuticals LLC
  • GenKyoTex SA
  • Genmab A/S
  • Genzyme Corp
  • Gismo Therapeutics Inc
  • GlaxoSmithKline Plc
  • Global BioLife Inc Ltd
  • GNT Pharma Co Ltd
  • Grespo AB
  • GT Gain Therapeutics SA
  • Guangzhou Magpie Pharmaceutical Co Ltd
  • Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd
  • H. Lundbeck AS
  • Hanmi Pharmaceuticals Co Ltd
  • Hebei Newtherapy BIo-Pharma Technology Co Ltd
  • Hemostemix Inc
  • Herantis Pharma Plc
  • HitGen LTD
  • Hong Kong WD Pharmaceutical Co Ltd
  • Hope Biosciences LLC
  • ICB International Inc
  • Icure Pharmaceutical Inc
  • ID Pharma Co Ltd
  • Imago Pharmaceuticals Inc
  • Immune Modulation Inc
  • Immungenetics AG
  • Impel NeuroPharma Inc
  • Inflazome Ltd
  • Inhibikase Therapeutics Inc
  • InnoMedica Holding AG
  • Intec Pharma Ltd
  • International Stem Cell Corp
  • Intra-Cellular Therapies Inc
  • Invisio Ltd
  • Io Therapeutics Inc
  • Ionis Pharmaceuticals Inc
  • IRLAB Therapeutics AB
  • Jazz Pharmaceuticals Plc
  • Jeil Pharmaceutical Co Ltd
  • Junaxo Inc
  • Kainos Medicine Inc
  • Kariya Pharmaceuticals IVS
  • Kashiv BioSciences LLC
  • Keapstone Therapeutics Ltd
  • Kissei Pharmaceutical Co Ltd
  • Kyowa Kirin Co Ltd
  • LA Cell Inc
  • Lauren Sciences LLC
  • Lead Discovery Center GmbH
  • Living Cell Technologies Ltd
  • Longevity Biotech Inc
  • Luye Pharma Group Ltd
  • Lysosomal Therapeutics Inc
  • M et P Pharma AG
  • Macrobian Biotech BV
  • Mavalon Therapeutics Ltd
  • Med-Life Discoveries LP
  • MedGenesis Therapeutix Inc
  • MeiraGTx Holdings Plc
  • Merck & Co Inc
  • Meta-IQ ApS
  • Metabolic Solutions Development Company LLC
  • MetVital Inc
  • MimeTech Srl
  • Minerva Neurosciences Inc
  • Mission Therapeutics Ltd
  • Mitochon Pharmaceuticals Inc
  • Mitoconix Bio Ltd
  • MitoDys Therapeutics Ltd
  • Mitokinin LLC
  • Mitsubishi Tanabe Pharma Corp
  • Modag GmbH
  • Montisera Ltd
  • Motac Neuroscience Ltd
  • Nanna Therapeutics Ltd
  • NeoCytex Biopharma Inc
  • Neonc Technologies Inc
  • Netherlands Translational Research Center BV
  • NeuBase Therapeutics Inc
  • NeuExcell Therapeutics Inc
  • Neuracle Science Co Ltd
  • Neuraly Inc
  • Neuren Pharmaceuticals Ltd
  • Neuro Vigor LLC
  • Neurocea Pharmaceuticals
  • Neurochlore
  • Neurodon LLC
  • Neurodyn Life Sciences Inc
  • Neuroene Therapeutics LLC
  • NeuroGeneration Inc
  • Neurona Therapeutics Inc
  • NeuroNascent Inc
  • NeuroPn Therapeutics LLC
  • Neuropore Therapies Inc
  • Neurotrope Bioscience Inc
  • New Amsterdam Sciences Inc
  • New Biotic Inc
  • New World Laboratories Inc
  • Newron Pharmaceuticals SpA
  • Nitrome Biosciences Inc
  • nLife Therapeutics SL
  • NLS Pharma Group
  • Novartis AG
  • Novo Nordisk AS
  • NTZ Lab Ltd
  • NutriBand Inc
  • Omeros Corp
  • Oncodesign SA
  • OPKO Health Inc
  • Orpheris Inc
  • Oryzon Genomics SA
  • Parkure Ltd
  • Peptron Inc
  • Pfizer Inc
  • Pharma Two B Ltd
  • PharmatrophiX Inc
  • Pharmicell Co Ltd
  • Pharnext SA
  • Phoenix Biotechnology Inc
  • Phoenix Life Sciences International Ltd
  • Pivot Pharmaceuticals Inc
  • PK Biosciences Corp
  • Plex Pharmaceuticals Inc
  • Polaryx Therapeutics Inc
  • PolyCore Therapeutics LLC
  • Prevail Therapeutics Inc
  • Priavoid GmbH
  • Primary Peptides Inc
  • Proclara Biosciences Inc
Note: Product cover images may vary from those shown
Adroll
adroll